Hosoya, Tatsuo
Furuno, Kazuki
Kanda, Shingo
Article History
Received: 17 September 2019
Accepted: 23 January 2020
First Online: 18 February 2020
Compliance with ethical standards
:
: TH was an advisor to Fuji Yakuhin Co., Ltd. regarding this study and received consultant and manuscript fees. KF and SK are employees of Mochida Pharmaceutical Co. Ltd.
: This study was conducted according to the Declaration of Helsinki, International Committee on Harmonization Good Clinical Practice guideline, and applicable local laws and regulations. The protocol was approved by the regulatory authorities in Japan and by the ethics committees of study center. All patients provided written informed consent before starting any procedure in this study. The information of this study was registered with ClinicalTrials.gov (Identifier: NCT03375632).
: This article is distributed under the terms of the Creative Commons Attribution 4.0 international license (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.